AN2 Therapeutics (2 presentations)

Company

AN2 Therapeutics

Healthcare

Biotechnology

Company description

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Quick Presentation Filters

Investor Presentation IPO